Guggenheim Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-33,462
| Closed | -$1.97M | – | 1966 |
|
|
2023
Q4 | $1.97M | Buy |
33,462
+2,557
| +8% | +$150K | 0.01% | 853 |
|
|
2023
Q3 | $1.35M | Buy |
30,905
+3,202
| +12% | +$139K | 0.01% | 967 |
|
|
2023
Q2 | $1M | Buy |
27,703
+265
| +1% | +$9.57K | 0.01% | 1155 |
|
|
2023
Q1 | $1.02M | Sell |
27,438
-17,875
| -39% | -$665K | 0.01% | 1172 |
|
|
2022
Q4 | $2.05M | Buy |
45,313
+20,973
| +86% | +$950K | 0.02% | 844 |
|
|
2022
Q3 | $1.7M | Sell |
24,340
-7,570
| -24% | -$529K | 0.02% | 901 |
|
|
2022
Q2 | $2.14M | Buy |
31,910
+4,110
| +15% | +$276K | 0.02% | 865 |
|
|
2022
Q1 | $2.29M | Buy |
27,800
+3,468
| +14% | +$285K | 0.01% | 947 |
|
|
2021
Q4 | $3.57M | Buy |
24,332
+3,437
| +16% | +$504K | 0.02% | 817 |
|
|
2021
Q3 | $3.7M | Sell |
20,895
-693
| -3% | -$123K | 0.02% | 784 |
|
|
2021
Q2 | $3.49M | Buy |
21,588
+552
| +3% | +$89.2K | 0.02% | 815 |
|
|
2021
Q1 | $3.6M | Buy |
21,036
+2,795
| +15% | +$479K | 0.02% | 762 |
|
|
2020
Q4 | $4.01M | Sell |
18,241
-2,981
| -14% | -$655K | 0.03% | 680 |
|
|
2020
Q3 | $3.52M | Sell |
21,222
-10,656
| -33% | -$1.77M | 0.03% | 665 |
|
|
2020
Q2 | $3.64M | Buy |
31,878
+6,941
| +28% | +$793K | 0.03% | 643 |
|
|
2020
Q1 | $1.92M | Sell |
24,937
-7,379
| -23% | -$567K | 0.02% | 803 |
|
|
2019
Q4 | $4.16M | Buy |
+32,316
| New | +$4.16M | 0.03% | 712 |
|
|
2019
Q3 | – | Sell |
-2,560
| Closed | -$263K | – | 2162 |
|
|
2019
Q2 | $263K | Buy |
+2,560
| New | +$263K | ﹤0.01% | 1923 |
|